Trial NCT03199963

View at ClinicalTrials.gov 
Org. Study IDs: BHR-700-301

Last trial update was posted on 2022-07-26

MeSH Interventions

Afimoxifene Tamoxifen

MeSH Conditions


Other Conditions

Mammographic Breast Density

Stopping Reasons

Administrative - change in development strategy

Limitations And Caveats

Other (Not Including Serious) Adverse Events entries are based on number of subject in the intention-to-treat (ITT) population (blinded phase, safety population). Includes all adverse events reported.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID